공시 • Feb 13
Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution Veradigm announced a new patient-reported outcomes (PRO) survey capability that brings the patient voice directly into real-world evidence generation. The new solution gives life sciences organizations timely, privacy-preserving insights directly from patients, adding essential context to clinical and observational research. Built on Veradigm's FollowMyHealth patient engagement platform, the capability enables individuals to securely share their experiences through an account they own and manage. Patients receive project-specific requests through trusted channels within FollowMyHealth, ensuring responses are authentic and relevant. Targeting logic helps reach the right patients quickly, and integrated consent and compensation streamline participation. Connecting the Full Patient Journey: Because of its nationally representative, diverse healthcare provider footprint, Veradigm is uniquely positioned to combine first-party clinical data from independent practices with direct patient input and point-of-care reach. This connected view helps innovators understand what truly drives outcomes and act with greater confidence. In 2025, Veradigm successfully completed and published a study demonstrating the feasibility of collecting PROs through FollowMyHealth and linking them with real-world data. The study validated the approach and confirmed the value of capturing patient experience alongside clinical information. By adding patient-reported information to existing real-world data, life sciences organizations gain a fuller picture of symptom burden, treatment experience, adherence, and quality-of-life factors. Benefits include: Patient-centered insights often missing from clinical documentation; Connected clinical and patient input for richer context; Trusted engagement through an established patient platform; Precision outreach to relevant patient groups; Integrated consent and compensation to reduce friction. New Risk • Feb 09
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 30% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Shares are highly illiquid. Earnings are forecast to decline by an average of 30% per year for the foreseeable future. 공시 • Jan 29
Veradigm Launches New AI Application for Powerful Revenue Cycle Insights for Independent Practices Veradigm announced the launch of a new AI-enabled application for Veradigm Revenue Cycle Services (RCS) clients, designed to deliver faster, deeper revenue cycle insights and strengthen the value of ongoing performance reviews for independent practices. Independent practices continue to face rising administrative complexity and financial pressure, driven by denials, payment variability, staffing constraints, and limited analytic visibility into what is driving revenue leakage. Veradigm RCS directly addresses these challenges by combining technology, expertise, and operational support to help practices improve cash flow and reduce revenue cycle burden. The new AI-enabled application is a web-based analytics workspace used by Veradigm's Revenue Cycle Services teams as part of their performance review process with clients. Instead of manually preparing and stitching together reports, analysts can now access an AI-generated view of denial trends, payment patterns, and operational bottlenecks in a single interface. The system automatically highlights anomalies, expands audit coverage, and surfaces emerging issues, allowing practices to see what is driving revenue leakage and where intervention is needed. Veradigm's new AI-enabled application is expected to reduce manual performance review preparation time by up to 25%, surface denial and payment trends automatically, and apply machine intelligence to expand audit coverage and reduce avoidable rework. Veradigm RCS is an end-to-end revenue cycle management solution designed to optimize financial performance for medical practices, with teams supporting everything from communicating with health plans to coding and claims, while integrating into existing electronic health record (EHR) and practice management workflows. Veradigm RCS consistently delivers top-tier financial outcomes for independent practices, achieving a 98% first-pass clean claims rate, 99% net collections, and 3-5% average revenue improvement in the first year. 공시 • Jan 16
Veradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain Integrity Veradigm and Meperia announced a strategic collaboration to launch a next-generation Electronic Data Interchange (EDI) solution, purpose-built for healthcare. This new EDI platform is designed to eliminate the friction, cost, and complexity of traditional EDI platforms through an industry-first 8-Way Match Framework. Built on a secure, cloud-based infrastructure supporting more than 16 million transactions, $5 billion in purchase volume, and unlimited supplier connections, the platform delivers hospital-first data governance tailored to provider needs and healthcare sustainability goals. The solution automatically validates each transaction against contracts, receipts, invoices, item masters, and rebate terms--minimizing errors, preventing overpayments, ensuring contract compliance, and enhancing rebate capture--all without manual intervention. By combining Veradigm's healthcare ERP platform spanning finance, supply chain, and point-of-use workflows, with Meperia's expertise in data governance, the collaboration delivers true end-to-end supply chain integrity. 
